Send me a link:

*Text messaging rates may apply.

 Dow Up0.36% Nasdaq Up0.71%

Akorn, Inc. (AKRX)

-NasdaqGS
34.48 Up 0.45(1.32%) Jul 22, 4:00PM EDT
|After Hours : 34.48 0.00 (0.00%) Jul 22, 4:29PM EDT
ProfileGet Profile for:
Akorn, Inc.
1925 West Field Court
Suite 300
Lake Forest, IL 60045
United States - Map
Phone: 847-279-6100
Website: http://www.akorn.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Drugs - Generic
Full Time Employees:1,099

Business Summary 

Akorn, Inc. manufactures and markets diagnostic and therapeutic ophthalmic pharmaceuticals, niche hospital drugs, and injectable pharmaceuticals in the United States and internationally. It offers products in various areas, including ophthalmology, antidotes, anti-infectives, pain management, anesthesia, vaccines, and others. The company operates in three segments: Ophthalmic, Hospital Drugs & Injectables, and Contract Services. The Ophthalmic segment markets diagnostic products, such as mydriatics and cycloplegics, anesthetics, topical stains, gonioscopic solutions, angiography dyes, and others for use in the office setting; therapeutic products, including antibiotics, steroids, steroid combinations, glaucoma medications, decongestants/antihistamines, and anti-edema medications to wholesalers, chain drug stores, and other national account customers; non-pharmaceutical products comprising artificial tear solutions, preservative-free lubricating ointments, and eyelid cleansers; and over-the-counter dry eye and other eye health products under the TheraTears name through chain drug stores and big box retailers, as well as directly to optometrists, ophthalmologists, and other eye care practitioners and clinics. This segment offers ophthalmic products, such as AzaSite, an azithromycin ophthalmic solution; Cosopt, a dorzolamide hydrochloride and timolol maleate ophthalmic solution; and Cosopt PF, a preservative-free prescription version of Cosopt. The Hospital Drugs & Injectables segment provides hospital drug and injectable pharmaceutical products comprising antidotes, anti-infectives, controlled substances for pain management and anesthesia, and other pharmaceutical products to hospitals through the wholesale distribution channel. The Contract Services segment manufactures various pharmaceutical products for third party pharmaceutical customers based on their specifications. The company was founded in 1971 and is headquartered in Lake Forest, Illinois.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Akorn, Inc.

Corporate Governance 
Akorn, Inc.’s ISS Governance QuickScore as of Jul 1, 2014 is 9. The pillar scores are Audit: 10; Board: 9; Shareholder Rights: 5; Compensation: 7.
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
 PayExercised
Mr. Rajat Rai , 47
Chief Exec. Officer
1.25M0.00
Mr. Timothy A. Dick , 44
Chief Financial Officer and Principal Accounting Officer
399.00K0.00
Dr. Bruce Kutinsky Pharm.D., 48
Chief Operating Officer
445.00K0.00
Mr. Joseph Bonaccorsi , 49
Sr. VP, Gen. Counsel and Sec.
413.00K0.00
Mr. John R. Sabat , 64
Sr. VP of National Accounts and Trade Relations
369.00K0.00
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders